These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 9828216

  • 41. Enoxaparin does not ameliorate liver fibrosis or portal hypertension in rats with advanced cirrhosis.
    Fortea JI, Zipprich A, Fernandez-Mena C, Puerto M, Bosoi CR, Almagro J, Hollenbach M, Bañares J, Rodríguez-Sánchez B, Cercenado E, Clément MA, Rose CF, Bañares R, Vaquero J, Ripoll C.
    Liver Int; 2018 Jan; 38(1):102-112. PubMed ID: 28665498
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Modified synthetic siRNA targeting tissue inhibitor of metalloproteinase-2 inhibits hepatic fibrogenesis in rats.
    Hu YB, Li DG, Lu HM.
    J Gene Med; 2007 Mar; 9(3):217-29. PubMed ID: 17351970
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Inhibitory effect of ursodeoxycholic acid on the progression of chronic hepatic disorders with special reference to increases in blood flow.
    Kurihara T, Akimoto M, Abe K, Hashimoto H, Ishiguro H, Niimi A, Maeda A, Shigemoto M, Yamashita K, Yokoyama I.
    Clin Ther; 1993 Mar; 15(5):866-74. PubMed ID: 8269453
    [Abstract] [Full Text] [Related]

  • 46. [Effects of nifedipine on hepatic hyaluronic acid, hydroxyproline and glucosaminidase contents in rats with liver fibrosis].
    Che J, Lu H, Li D.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Feb; 16(1):35-8. PubMed ID: 7954965
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Effect of octreotide on the pathology of hepatic schistosomiasis.
    Mansy SS, Yehia HA, Hassan MM, Hassan EA, Youssef MM, Hadi AA, Mackenzie CD.
    Arzneimittelforschung; 1998 Aug; 48(8):855-61. PubMed ID: 9748716
    [Abstract] [Full Text] [Related]

  • 49. Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis.
    Abdel Aziz MT, Atta HM, Mahfouz S, Fouad HH, Roshdy NK, Ahmed HH, Rashed LA, Sabry D, Hassouna AA, Hasan NM.
    Clin Biochem; 2007 Aug; 40(12):893-9. PubMed ID: 17543295
    [Abstract] [Full Text] [Related]

  • 50. Hepatic sinusoidal fibrosis induced by cholesterol and stilbestrol in the rabbit: 1. Morphology and inhibition of fibrogenesis by dipyridamole.
    Wanless IR, Belgiorno J, Huet PM.
    Hepatology; 1996 Oct; 24(4):855-64. PubMed ID: 8855188
    [Abstract] [Full Text] [Related]

  • 51. The effect of hepatocyte enlargement on the hemodynamic characteristics of the isolated perfused rat liver preparation.
    Grossman HJ, Grossman VL, Bhathal PS.
    Hepatology; 1998 Feb; 27(2):446-51. PubMed ID: 9462643
    [Abstract] [Full Text] [Related]

  • 52. Antifibrotic effect of Stephania tetrandra on experimental liver fibrosis induced by bile duct ligation and scission in rats.
    Nan JX, Park EJ, Lee SH, Park PH, Kim JY, Ko G, Sohn DH.
    Arch Pharm Res; 2000 Oct; 23(5):501-6. PubMed ID: 11059831
    [Abstract] [Full Text] [Related]

  • 53. Efects of melatonin and octreotide on peridural fibrosis in an animal model of laminectomy.
    Erol FS, Kavakli A, Ilhan N, Ozercan IH, Sarsilmaz M.
    Turk Neurosurg; 2010 Jan; 20(1):50-6. PubMed ID: 20066622
    [Abstract] [Full Text] [Related]

  • 54. [In vitro contractility behavior of portal veins in normal rats and in rats with liver cirrhosis--effect of calcium antagonists and octreotide].
    Hanisch E, Strasse R, Wenzel M, Lorey T.
    Z Gastroenterol; 1993 Oct; 31(10):600-4. PubMed ID: 8256474
    [Abstract] [Full Text] [Related]

  • 55. Effects of octreotide on intestinal transit and bacterial translocation in conscious rats with portal hypertension and liver fibrosis.
    Veal N, Auduberteau H, Lemarie C, Oberti F, Calès P.
    Dig Dis Sci; 2001 Nov; 46(11):2367-73. PubMed ID: 11713937
    [Abstract] [Full Text] [Related]

  • 56. Hemodynamic effects of acute and chronic administration of vapreotide in rats with cirrhosis.
    Veal N, Moal F, Oberti F, Vuillemin E, Calés P.
    Dig Dis Sci; 2003 Jan; 48(1):154-61. PubMed ID: 12645803
    [Abstract] [Full Text] [Related]

  • 57. Splenorenal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats.
    Calès P, Oberti F, Veal N, Fort J, Kaassis M, Moal F, Aubé C, Vuillenin E, Pilette C, Rifflet H, Trouvé R.
    Hepatology; 1998 Nov; 28(5):1269-74. PubMed ID: 9794911
    [Abstract] [Full Text] [Related]

  • 58. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation.
    Poo JL, Feldmann G, Moreau A, Gaudin C, Lebrec D.
    J Hepatol; 1993 Aug; 19(1):90-4. PubMed ID: 8301049
    [Abstract] [Full Text] [Related]

  • 59. Antifibrotic effects of a polysaccharide extracted from Ganoderma lucidum, glycyrrhizin, and pentoxifylline in rats with cirrhosis induced by biliary obstruction.
    Park EJ, Ko G, Kim J, Sohn DH.
    Biol Pharm Bull; 1997 Apr; 20(4):417-20. PubMed ID: 9145221
    [Abstract] [Full Text] [Related]

  • 60. Blood digestion-induced splanchnic hyperemia and portal blood flow in portal hypertensive rats and the role of octreotide.
    Kotzampassi K, Eleftheriadis E.
    J Gastroenterol; 1998 Oct; 33(5):678-83. PubMed ID: 9773932
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.